Drug utilization pattern of antiseizure drugs and their adverse effects in the pediatric population, in a tertiary care hospital attached to a medical college
Keywords:Epilepsy, Drug utilization pattern, Adverse drug reaction
Background: Epilepsy is “a condition characterized by recurrent (two or more) seizure, unprovoked by any immediate identified cause.” The desired outcome of antiseizure drug (ASD) therapy is to be seizure-free throughout the rest of life. The objective was to study the utilization pattern and adverse drug reactions (ADRs) associated with the use of ASDs in pediatric outpatients in epilepsy clinic.
Methods: This cross-sectional, observational and single center study was carried out over a period of 1 year in 430 pediatric patients. Analyzed data included demographic details and drugs prescribed in respective seizure types along with ADRs due to ASDs. Results: In a total 430 patients analyzed, seizure were most commonly observed in boys (69.8%) in 6-10 year of age (45.3%), with a positive family history in (16%), with no specific cause of seizure in (71.6%), with most common type was focal seizure in (62.3%), which was mainly treated with carbamazepine (73.8%). Most common ADR was irritability (32.2%) with Valproate being main drug. 87.3% ADRs were in “ possible” as per World Health Organization causality assessment scale, 94.9% ADRs were “mild” as per Hartwig and Siegel severity assessment scale and 98.3% ADRs were “preventable” as per Schumock and Thornton preventability scale.
Conclusion: Focal seizure was most common type of seizure observed mainly in boys of 6-10 year with carbamazepine as mainly prescribed drug. Use of appropriate ASDs in the majority of patients as per guidelines, has decreased number of ADRs in our study. Prescribing drugs were mainly from essential drug list and by generic names.
Lowenstein DH. Seizures and epilepsy. In: Anthony SF, Dennis LK, Dan LL, Braunwald E, Stephen LH, Larry J, et al, editors. Harrison's Principles of Internal Medicine. 18th ed. New Delhi: The McGraw-Hill; 2011: 3251-70.
White HS. Mechanism of antiepileptic drugs. In: Porter RJ, Chadwick D, editors. The Epilepsies 2. Blue Books of Practical Neurology. Boston: Butterworth-Heinemann-1; 1997: 1-30.
World Health Organization (WHO). Introduction to drug utilisation research/WHO International Working Group for Drug Statistics Methodology, WHO Collaborating centre for Drug statistics Methodology, WHO collaborating centre for Drug Utilisation Research and Clinical Pharmacological services. Geneva: WHO Press, World Health Organization; (Online) 2003. Available from: http://www.whocc.no/filearchive/publications/drug_utilization_research.pdf. [Last accessed on 2014 Jan 16]. [Last cited on 2003].
Deckers CL. Place of polytherapy in the early treatment of epilepsy. CNS Drugs. 2002;16:155-63. [DOI via Crossref]
Nahata MC, Taketomo C. Pediatrics. In: Dipiro JT, Talbent RL, editors. Pharmacotherapy a Pathophysiological Approach. 6th ed. New Delhi: The McGraw-Hill; 2002: 91-101.
Ormand BA. Awareness and access to care for children and youth with epilepsy. Maternal and Family Health Administration, the District of Columbia. (Online) 2006. Available from: http://www.urban.org/uploadedpdf/411373_youth_epilepsy.pdf. Last accessed on 2014 Jan 16]. [Last cited on 2006 Oct].
Hasan SS, Bahari MB, Babar ZU, Ganesan V. Antiepileptic drug utilisation and seizure outcome among paediatric patients in a Malaysian public hospital. Singapore Med J. 2010;51:21-7.
Inaam NM, Maha AM, Ahlam AR. The profile of childhood epilepsy in Sudan. Khartoum Med J. 2010;03:444-7.
World Health Organization (WHO). Primary prevention of mental, neurological, psychological disorder. Geneva: WHO Press, World Health Organization (Online); 1998. Available from: http://www.who.int/mental_health/evidence/en/prevention_of_mental_disorders_sr.pdf. [Last accessed on 2014 Jan 16]. [Last cited on 2004].
Ravat SH, Gupta R. Antiepileptic drugs in pediatric epilepsy. J Pediatr Neurosci. 2008;3:7-15. [DOI via Crossref]
Michel VJ. Seizures in childhood. In: Robert MK, Richard EB, Hal BJ, Bonita FS, editors. Nelson Textbook of Pediatrics. 18th ed. New Delhi: Saunders Elsevier; 2007. p. 2457-73.
Hanseens Y, Daleu D, Balushi K, Hashar A, Zakwani I. Drug utilization pattern of antiepileptic drugs: a pharmacoepidemiologic study in Oman. J Clin Pharm Thera 2002;27:357-64. [DOI via Crossref]
Krumholz A, Wiebe S, Gronseth G, Shinar S, Levisohn P, Ting T, et al. Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology and the American epilepsy society. Neurology. 2007;69:1996-2007. [DOI via Crossref]
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH. Revised terminology and concepts for organization of seizure and epilepsies: report of the ILAE commission on classification and terminology: 2005-2009. Epilepsia. 2010;51:676-85. [DOI via Crossref]
Larsson K, Eeg-Olofsson O. A population based study of epilepsy in children from a Swedish county. Eur J Peadiatr Neurol. 2006;10:107-13. [DOI via Crossref]
Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of epilepsy in children and young people - A national clinical guideline. (Online). March 2005. Available from: http://www.sign.ac.uk/pdf/sign81.pdf. [Last accessed on 2014 Jan 17]. [Last cited on 2005 Mar].
National Institute for Clinical Excellence (NICE). The epilepsies: diagnosis and management of epilepsy in children and young people in primary and secondary care. Clinical guideline. (Online). October 2004. Available from: http://www.nice.org.uk/nicemedia/pdf/CG020publicinfoenglish.pdf. [Last accessed on 2014 Jan 17]. [Last cited 2004 Oct].
Chen LC, Chen YF, Yang LL, Chou MH, Lin MF. Drug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan - A pharmaco-epidemiologic study. J Clin Pharm Ther. 2000;25:125-9. [DOI via Crossref]
Radhakrishanan K, Nayak SD, Kumar SP, Sarma PS. Profile of antiepileptic pharmacotherapy in tertiary referral center in south India: a pharmacoepidemiology and phamracoeconomic study. Epilepsia. 1999;40:179-85. [DOI via Crossref]
Ab Rahman AF, Mohamed MF, Mohamed HI, Sang TB. The use of lamotrigine and other antiepileptic drugs in pediatric patients at a Malaysian hospital. Pharm World Sci. 2005;27:403-6. [DOI via Crossref]
Kariyawasam SH, Bandara N, Koralagama A, Senanayake S. Challenging epilepsy with antiepileptic pharmacotherapy in a tertiary teaching hospital in Sri Lanka. Neurol India. 2004;52:233-7.
World Health Organization (WHO). 3rd WHO model list of essential medicines for children, March 2011 [Online]. Available from: http://www.whqlibdoc.who.int/hq/2011/a95053_eng.pdf. [Last accessed on 2012 Nov 20].
National list of essential medicines of India 2011 [Online]. Available from URL: http://www.pharmaceuticals.gov.in/NLEM.pdf. http://www.whqlibdoc.who.int/hq/2011/a95053_eng.pdf. [Last accessed on 2012 Nov 20].
Palanisamy S, Arulkumaran KSG, Rajasekaran A. A study on drug use evaluation of anti-epileptics at a multispecialty tertiary care teaching hospital. Int J PharmTech Res. 2009;1:1541-7.
James OM. Pharmacotherapy of epilepsy. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gillman's the Pharmacological Basis of Therapeutics. 12th ed. New Delhi: The McGraw-Hill Companies; 2011: 583-607.
Jha N, Bajracharya O, Namgyal T. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. Kathmandu Univ Med J. 2007;5:504-10.
Sen S, Mathur S, Ramesh L, Kumar SM. Utilization pattern of antiepileptic drugs and their adverse effects, in a teaching hospital. Asian J Pharm Clin Res. 2010;3:55-9.
WHO-UMC system for standardized case causality assessment. (Online) 2007 April 17. Available from: http://www.who-umc.org/graphics/4409.pdf. [Last accessed on 2009 Dec 12]. [Last cited on 2009 Dec 12].
Hartwig SC, Siegel J, Schneider PJ. Preventibility and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.